SARS-CoV-2 omicron variant may evade host immune responses

A recent study has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 has a higher ability to evade antibody-mediated neutralization than other variants of concern.

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines - Araf - 2022 - Journal of Medical Virology - Wiley Online Library

Study helps explain SARS-CoV-2 variants' rapid spread - UW Medicine

Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months - eBioMedicine

SARS-CoV-2 Brazilian variant may potentially escape T cell-mediated host immune responses

SARS-CoV-2 learned the 'Alpha'bet of immune evasion

Vaccines, Free Full-Text

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic - ScienceDirect

Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron - ScienceDirect

SARS-CoV-2 variant biology: immune escape, transmission and fitness

Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines

Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants

What to Know About EG.5 (Eris)—the Latest Coronavirus Strain > News > Yale Medicine